Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Zapoteca portoricensis extract may help protect against prostate issues and support liver and kidney health in rats.

Dutasteride is more cost-effective than finasteride for treating benign prostatic hyperplasia in Montenegro.

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.

COVID-19 may worsen symptoms of benign prostatic hyperplasia (BPH).

Tamsulosin for enlarged prostate may increase the risk of severe low blood pressure, especially when starting or restarting the medication.

Cinnamomi cortex may help treat prostate enlargement by reducing related proteins.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Corn silk extract helps reduce prostate enlargement symptoms.

α-spinasterol from Melandrium firmum can help reduce prostate enlargement.

Caesalpinia bonduc seed extracts may help treat enlarged prostate in rats.

Taking finasteride before surgery reduces blood loss in prostate procedures.

Purple corn extract may help reduce prostate enlargement and inflammation.

Dutasteride and finasteride have similar effects on prostate cancer risk in BPH patients.

Certain gene variants may raise the risk of prostate enlargement, but taking NSAIDs could reduce this risk.

Early hair loss may indicate prostate issues.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Hair loss linked to prostate enlargement; stress and family history important factors.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Treatment for benign prostatic hyperplasia involves drugs that either quickly relieve symptoms or reduce prostate size, with a combination offering more benefits but more side effects.

Medical treatments for benign prostatic hyperplasia mainly relieve symptoms, while surgery is more effective but not always suitable for elderly patients.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

5α-reductase inhibitors help manage symptoms of benign prostatic hyperplasia and may also prevent prostate cancer and treat hair loss.

Finasteride reduces urinary issues and surgery need in men with enlarged prostates by over 50%.